CORE B ? BIOANALYTICAL, MASS SPECTROSCOPY, IMAGING AND HISTOLOGY CORE PROJECT SUMMARY/ABSTRACT The Cardiorenal and Metabolic Diseases Research Center (CMDRC) was established to enhance research infrastructure and provide mentoring to increase the ability of COBRE investigators to successfully compete for independent NIH funding. The Bioanalytical, Mass Spectroscopy, Imaging and Histology Core B was established as a resource for the CMDRC during Phase I, and this core has had a transformative effect on COBRE junior investigators, Pilot Grant investigators, and investigators from local Historically Black Colleges and Universities (HBCUs). During Phase I of COBRE support, Core B established services critical to cardiorenal and metabolic diseases researchers in addition to numerous investigators who collaborate with members of the CMDRC. Core B provides access to technologies and services that would otherwise not be available in Mississippi. This includes consolidated, highly specialized services and state-of-the-art resources staffed by professional personnel who are not only capable of performing a variety of essential research services, but are also able to provide training and assist in the development of new research methods to meet the changing needs of COBRE investigators. Core B has multiple components including the Bioanalytical/Mass Spec Sub-Cores that provide centralized radioimmunoassay (RIA), ELISA, HPLC, LC/Mass spectroscopy, proteomics, lipidomics and other biochemical/chemistry analyses, and the Histology/Imaging Sub-Cores that provide access to state-of?the-art imaging equipment as well as histology, immunohistochemistry, and other key services. Faculty from over 15 different basic science and clinical departments at UMMC in addition to researchers from other institutions including Jackson State University, a HBCU, used services and resources provided by Core B during Phase I of COBRE support. Resources and services provided by Core B were substantially expanded during Phase I and this was supported by the addition of new state-of-the-art equipment to each Sub-Core. Usage of Core B by investigators facilitated the generation of >250 publications and provided direct support for the receipt of many extramural funded grants from NIH and other non-profit funding agencies. Establishment of Sub-Cores as Recharge Centers initiated our business plan for sustainability and Core B will continue to build upon our success so that we can provide continuous support for existing infrastructure, resources and services, and expand Core offerings to meet the needs of cardiorenal and metabolic disease researchers at UMMC.

Public Health Relevance

CORE B ? BIOANALYTICAL, MASS SPECTROSCOPY, IMAGING AND HISTOLOGY CORE PROJECT NARRATIVE The Bioanalytical, Mass Spectroscopy, Imaging and Histology Core B provides access to technologies and services that would otherwise not be available in Mississippi. This includes the Bioanalytical/Mass Spec Sub- Cores that provide centralized radioimmunoassay (RIA), ELISA, HPLC, LC/Mass spectroscopy, proteomics, lipidomics and other biochemical/chemistry analyses and the Histology and Imaging Sub-Cores that provide access to state-of?the-art imaging equipment as well as histology, immunohistochemistry, in-situ hybridization and other key services. This Core is staffed by professional personnel who are not only capable of performing a variety of essential research services, but are also able to provide training and assist in the development of new research methods to meet the changing needs of COBRE investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM104357-08
Application #
9920746
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
8
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Mississippi Medical Center
Department
Type
DUNS #
928824473
City
Jackson
State
MS
Country
United States
Zip Code
39216
Hoshide, Satoshi; Yano, Yuichiro; Mizuno, Hiroyuki et al. (2018) Day-by-Day Variability of Home Blood Pressure and Incident Cardiovascular Disease in Clinical Practice: The J-HOP Study (Japan Morning Surge-Home Blood Pressure). Hypertension 71:177-184
Lindsey, Merry L; Bolli, Roberto; Canty Jr, John M et al. (2018) Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol 314:H812-H838
Chen, Xu; Li, Xuan; Zhang, Wenyan et al. (2018) Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-?B pathway. Metabolism 83:256-270
Ma, Yonggang; Mouton, Alan J; Lindsey, Merry L (2018) Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl Res 191:15-28
Roman, Richard J; Fan, Fan (2018) Genetic Susceptibility to Hypertension-Induced Renal Injury. Hypertension 71:559-560
Kamimura, Daisuke; Cain, Loretta R; Mentz, Robert J et al. (2018) Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study. Circulation 137:2572-2582
Mouton, Alan J; DeLeon-Pennell, Kristine Y; Rivera Gonzalez, Osvaldo J et al. (2018) Mapping macrophage polarization over the myocardial infarction time continuum. Basic Res Cardiol 113:26
Meschiari, Cesar A; Jung, Mira; Iyer, Rugmani Padmanabhan et al. (2018) Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction. Am J Physiol Heart Circ Physiol 314:H224-H235
Hinds Jr, Terry D; Stec, David E (2018) Bilirubin, a Cardiometabolic Signaling Molecule. Hypertension 72:788-795
Adeosun, Samuel O; Moore, Kyle H; Lang, David M et al. (2018) A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity. React Oxyg Species (Apex) 5:35-45

Showing the most recent 10 out of 254 publications